SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-045997
Filing Date
2024-11-07
Accepted
2024-11-07 08:01:42
Documents
16
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vcel-20241107.htm   iXBRL 8-K 34531
2 EX-99.1 ex991earningsreleaseq32024.htm EX-99.1 138452
6 vericellogoa26.jpg GRAPHIC 48734
  Complete submission text file 0001628280-24-045997.txt   383476

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcel-20241107.xsd EX-101.SCH 2404
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcel-20241107_lab.xml EX-101.LAB 22150
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcel-20241107_pre.xml EX-101.PRE 13056
18 EXTRACTED XBRL INSTANCE DOCUMENT vcel-20241107_htm.xml XML 2697
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

IRS No.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35280 | Film No.: 241433282
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)